Antonio Regalado
Biotechnology Writer at MIT Technology Review
Progress in science depends on new techniques, new discoveries and new ideas, probably in that order - {Sydney Brenner}. I write about biotech @MIT @techreview
Articles
-
2 weeks ago |
technologyreview.com | Caiwei Chen |Antonio Regalado
Since the Chinese biophysicist He Jiankui was released from prison in 2022, he has sought to make a scientific comeback and to repair his reputation after a three-year incarceration for illegally creating the world’s first gene-edited children. While he has bounced between cities, jobs, and meetings with investors, one area of visible success on his come-back trail has been his X.com account, @Jiankui_He, which has become his main way of spreading his ideas to the world.
-
2 weeks ago |
technologyreview.es | Antonio Regalado
Las patentes CRISPR vuelven a estar en juego. Este lunes Tribunal de Apelación del Circuito Federal de EE UU declaró que las científicas Jennifer Doudna y Emmanuelle Charpentier tendrán otra oportunidad de demostrar que merecen ser las propietarias de las patentes clave de lo que muchos consideran el invento biotecnológico más importante del siglo XXI.
-
2 weeks ago |
heise.de | Antonio Regalado
Mediziner und Forscher aus Philadelphia berichten, dass sie ein Baby mit einer tödlichen Stoffwechselerkrankung erfolgreich behandelt haben. Dafür hatten sie zuvor in weniger als sieben Monaten eine maßgeschneiderte Gentherapie entwickelt. Dies sei laut eines Berichts im New England Journal of Medicine der erste Fall, in dem die Genbearbeitung auf die Behandlung einer einzelnen Person zugeschnitten wurde.
-
3 weeks ago |
technologyreview.es | Antonio Regalado
Un grupo de médicos afirma haber creado un tratamiento de edición genética a medida en menos de siete meses y haberlo utilizado para tratar a un bebé con una enfermedad metabólica mortal. El rápido intento de reescribir el ADN del niño supone la primera vez que la edición de genes se adapta para tratar a un solo individuo, según un informe publicado en el New England Journal of Medicine.
-
3 weeks ago |
technologyreview.com | Antonio Regalado
The baby who was treated, Kyle “KJ” Muldoon Jr., suffers from a rare metabolic condition caused by a particularly unusual gene misspelling. Researchers say their attempt to correct the error demonstrates the high level of precision new types of gene editors offer. “I don’t think I’m exaggerating when I say that this is the future of medicine,” says Kiran Musunuru, an expert in gene editing at the University of Pennsylvania whose team designed the drug.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 27K
- Tweets
- 24K
- DMs Open
- Yes
Smith was posting from a Musk implant, with the help of Musk's AI, on a Musk media platform and in reply to a Musk fanboy, if not actually the “alt” of the richest person in the world. So it’s fair to ask: Where does Smith end and Musk’s ecosystem begin? https://t.co/j0Q1fCY6kM
Ouch. One of the original founders of 23andMe advises public to delete accounts, given lack of "reputable" bidders for the failing company and its data.
Based on what I’m hearing on the bids for 23andMe, I think it makes most sense for customers to download their data first, then delete their accounts. Some of the more reputable bidders are deciding to drop out, given all the challenges 23andMe faces. In the future, there may be
Trum executive order banning US funding of gain-of-function virus research overseas. Seems to open the door to a general ban on certain research w/ fed funds. Private funding loophole? https://t.co/38RBQ6uOi9
'There's no laboratory that does this right, there's no laboratory that’s immune from leaks,' Health Secretary Robert F. Kennedy Jr. said. 'This is going to prevent these kind of inadvertent leaks from happening in the future and endangering humanity.'" https://t.co/ZQv1oef7Xh?
